Skip to main content

Table 1 Subject characteristics at visit 2

From: Effectiveness of wearable devices as a support strategy for maintaining physical activity after a structured exercise intervention for employees with metabolic syndrome: a randomized controlled trial

Parameter

A

B

C

p-value

Female / male

5 / 38

8 / 35

6 / 37

0.649

Age (yrs)

50.3 ± 7.2

47.9 ± 8.2

47.6 ± 7.5

0.194

Body weight (kg)

102.8 ± 19.0

99.7 ± 15.9

99.8 ± 16.8

0.638

Body mass index (kg/m2)

32.0 ± 5.4

31.4 ± 4.7

31.3 ± 4.5

0.742

Waist circumference (cm)

    

 Female

106.6 ± 8.3

107.6 ± 11.0

102.7 ± 8.2

0.623

 Male

111.1 ± 13.1

107.9 ± 12.2

108.3 ± 12.4

0.481

Fasting glucose concentration (mg/dl)

111.3 ± 35.8

99.1 ± 15.7

102.9 ± 17.5

0.071

Triglyceride (mg/dl)

180.6 ± 207.8

153.3 ± 94.9

191.8 ± 140.0

0.491

HDL (mg/dl)

44.5 ± 8.9

47.5 ± 8.6

43.5 ± 9.5

0.111

Resting RRsys (mmHg)

129.9 ± 10.1

129.5 ± 11.8

133.2 ± 11.3

0.140

MetS-z-score

0.75 ± 0.85

0.47 ± 0.64

0.72 ± 0.71

0.232

  1. Subgroup A—wearables and personal consultation, Subgroup B—wearables only, Subgroup C—no technical or personal support
  2. HDL high density lipoprotein